A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
To investigate the efficacy of 0.3% OPA-15406 ointment when administered twice daily for 4
weeks in infants younger than 2 years of age with Atopic Dermatitis